Cargando…

Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny

The study objectives were: 1) to characterise the development of immunocompetence in beef suckler calves from birth to three months of age, and 2) to trace glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) antibodies from dam to calf and subsequent vaccination against pneumonia. Thirty...

Descripción completa

Detalles Bibliográficos
Autores principales: Earley, Bernadette, Tiernan, Katie, Duffy, Catherine, Dunn, Amanda, Waters, Sinead, Morrison, Steven, McGee, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111865/
https://www.ncbi.nlm.nih.gov/pubmed/29421483
http://dx.doi.org/10.1016/j.rvsc.2018.01.005
_version_ 1783513374237130752
author Earley, Bernadette
Tiernan, Katie
Duffy, Catherine
Dunn, Amanda
Waters, Sinead
Morrison, Steven
McGee, Mark
author_facet Earley, Bernadette
Tiernan, Katie
Duffy, Catherine
Dunn, Amanda
Waters, Sinead
Morrison, Steven
McGee, Mark
author_sort Earley, Bernadette
collection PubMed
description The study objectives were: 1) to characterise the development of immunocompetence in beef suckler calves from birth to three months of age, and 2) to trace glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) antibodies from dam to calf and subsequent vaccination against pneumonia. Thirty multiparous beef suckler, spring-calving cows, consisting of two genotypes were involved; Limousin × Friesian (LF) and Charolais × Limousin (CL). Cows were immunised against the inactivated antigen strain of BoHV-1 (gE- (IBR marker vaccine) at day − 84 and received a booster at day − 56 relative to the expected calving date (d 0). Calves were immunised at 14 and 42 days of age against PI-3 virus, BRSV and Mannheimia (Pasteurella) haemolytica serotype A1 using a commercial vaccine administered subcutaneously. Additionally, calves were immunised against BoHV-1 at 42 days of age, using 1 dose of a live commercial vaccine administered intranasally. Blood samples were collected from all calves (n = 30) via jugular venipuncture at birth, prior to colostrum feeding (0 h), at 12 h (h), 24 h, 72 h and 168 h after the initial feeding of colostrum, and at d 7, 14, 28, 42, 56 and 84 post birth. The mean ratio of gE negative antibodies circulating in the blood of LF and CL dams pre-partum scored negative to gE ab (S/N ≥ 0.70). Antibody levels of BoHV-1 (wild type (wt)) peaked at 12 h post-birth in calves and declined thereafter, as the maternal antibodies decayed. There was no difference in BoHV-1 and BRSV antibody levels in calves post vaccination.
format Online
Article
Text
id pubmed-7111865
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71118652020-04-02 Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny Earley, Bernadette Tiernan, Katie Duffy, Catherine Dunn, Amanda Waters, Sinead Morrison, Steven McGee, Mark Res Vet Sci Article The study objectives were: 1) to characterise the development of immunocompetence in beef suckler calves from birth to three months of age, and 2) to trace glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) antibodies from dam to calf and subsequent vaccination against pneumonia. Thirty multiparous beef suckler, spring-calving cows, consisting of two genotypes were involved; Limousin × Friesian (LF) and Charolais × Limousin (CL). Cows were immunised against the inactivated antigen strain of BoHV-1 (gE- (IBR marker vaccine) at day − 84 and received a booster at day − 56 relative to the expected calving date (d 0). Calves were immunised at 14 and 42 days of age against PI-3 virus, BRSV and Mannheimia (Pasteurella) haemolytica serotype A1 using a commercial vaccine administered subcutaneously. Additionally, calves were immunised against BoHV-1 at 42 days of age, using 1 dose of a live commercial vaccine administered intranasally. Blood samples were collected from all calves (n = 30) via jugular venipuncture at birth, prior to colostrum feeding (0 h), at 12 h (h), 24 h, 72 h and 168 h after the initial feeding of colostrum, and at d 7, 14, 28, 42, 56 and 84 post birth. The mean ratio of gE negative antibodies circulating in the blood of LF and CL dams pre-partum scored negative to gE ab (S/N ≥ 0.70). Antibody levels of BoHV-1 (wild type (wt)) peaked at 12 h post-birth in calves and declined thereafter, as the maternal antibodies decayed. There was no difference in BoHV-1 and BRSV antibody levels in calves post vaccination. Elsevier Ltd. 2018-06 2018-01-10 /pmc/articles/PMC7111865/ /pubmed/29421483 http://dx.doi.org/10.1016/j.rvsc.2018.01.005 Text en © 2018 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Earley, Bernadette
Tiernan, Katie
Duffy, Catherine
Dunn, Amanda
Waters, Sinead
Morrison, Steven
McGee, Mark
Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny
title Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny
title_full Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny
title_fullStr Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny
title_full_unstemmed Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny
title_short Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny
title_sort effect of suckler cow vaccination against glycoprotein e (ge)-negative bovine herpesvirus type 1 (bohv-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111865/
https://www.ncbi.nlm.nih.gov/pubmed/29421483
http://dx.doi.org/10.1016/j.rvsc.2018.01.005
work_keys_str_mv AT earleybernadette effectofsucklercowvaccinationagainstglycoproteinegenegativebovineherpesvirustype1bohv1onpassiveimmunityandphysiologicalresponsetosubsequentbovinerespiratorydiseasevaccinationoftheirprogeny
AT tiernankatie effectofsucklercowvaccinationagainstglycoproteinegenegativebovineherpesvirustype1bohv1onpassiveimmunityandphysiologicalresponsetosubsequentbovinerespiratorydiseasevaccinationoftheirprogeny
AT duffycatherine effectofsucklercowvaccinationagainstglycoproteinegenegativebovineherpesvirustype1bohv1onpassiveimmunityandphysiologicalresponsetosubsequentbovinerespiratorydiseasevaccinationoftheirprogeny
AT dunnamanda effectofsucklercowvaccinationagainstglycoproteinegenegativebovineherpesvirustype1bohv1onpassiveimmunityandphysiologicalresponsetosubsequentbovinerespiratorydiseasevaccinationoftheirprogeny
AT waterssinead effectofsucklercowvaccinationagainstglycoproteinegenegativebovineherpesvirustype1bohv1onpassiveimmunityandphysiologicalresponsetosubsequentbovinerespiratorydiseasevaccinationoftheirprogeny
AT morrisonsteven effectofsucklercowvaccinationagainstglycoproteinegenegativebovineherpesvirustype1bohv1onpassiveimmunityandphysiologicalresponsetosubsequentbovinerespiratorydiseasevaccinationoftheirprogeny
AT mcgeemark effectofsucklercowvaccinationagainstglycoproteinegenegativebovineherpesvirustype1bohv1onpassiveimmunityandphysiologicalresponsetosubsequentbovinerespiratorydiseasevaccinationoftheirprogeny